{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:43:23Z","timestamp":1791362603606,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neo.2022.100866","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:55:57Z","timestamp":1672314957000},"page":"100866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0946-5923","authenticated-orcid":false,"given":"Amrita","family":"Salvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-3005","authenticated-orcid":false,"given":"Laura R.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3216-4272","authenticated-orcid":false,"given":"Kimberly N.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Watry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1197-4057","authenticated-orcid":false,"given":"Melissa R.","family":"Pergande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-6847","authenticated-orcid":false,"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neo.2022.100866_bib0001","article-title":"PARP inhibitors as frontline treatment in patients with ovarian cancer","volume":"34","author":"Wright","year":"2020","journal-title":"Oncology (Williston Park, NY)"},{"issue":"8","key":"10.1016\/j.neo.2022.100866_bib0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers10080242","article-title":"The tumor microenvironment of epithelial ovarian cancer and its influence on response to immunotherapy","volume":"10","author":"Rodriguez","year":"2018","journal-title":"Cancers"},{"issue":"5659","key":"10.1016\/j.neo.2022.100866_bib0003","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-\u00df signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neo.2022.100866_bib0004","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.neo.2022.100866_bib0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A collagen-remodeling gene signature regulated by TGF\u03b2 signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2022.100866_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2020.00641","article-title":"Shaping up the tumor microenvironment with cellular fibronectin","volume":"10","author":"Efthymiou","year":"2020","journal-title":"Front. Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cells9010149","article-title":"Fibronectin and periostin as prognostic markers in ovarian cancer","volume":"9","author":"Kujawa","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cbin.10184","article-title":"Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK\u2013PI3K\/Akt pathway","volume":"38","author":"Yousif","year":"2014","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.neo.2022.100866_bib0009","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12964-020-00580-3","article-title":"Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype","volume":"18","author":"Yokoi","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neo.2022.100866_bib0011","doi-asserted-by":"crossref","first-page":"e59442","DOI":"10.7554\/eLife.59442","article-title":"Collagen-rich omentum is a premetastatic niche for integrin \u03b12-mediated peritoneal metastasis","volume":"9","author":"Huang","year":"2020","journal-title":"Elife"},{"issue":"suppl 10","key":"10.1016\/j.neo.2022.100866_bib0012","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.neo.2022.100866_bib0013","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/dev.091785","article-title":"Pax genes: regulators of lineage specification and progenitor cell maintenance","volume":"141","author":"Blake","year":"2014","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.neo.2022.100866_bib0014","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.neo.2022.100866_bib0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.humpath.2015.03.017","article-title":"PAX8 expression in ovarian surface epithelial cells","volume":"46","author":"Adler","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.neo.2022.100866_bib0016","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1038\/s41388-019-0842-2","article-title":"Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton","volume":"1","author":"Hardy","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.neo.2022.100866_bib0017","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2022.100866_bib0018","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cancers10080262","article-title":"UnPAXing the divergent roles of PAX2 and PAX8 in high-grade serous ovarian cancer","volume":"10","author":"Hardy","year":"2018","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.neo.2022.100866_bib0019","doi-asserted-by":"crossref","first-page":"32785","DOI":"10.18632\/oncotarget.9051","article-title":"Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium","volume":"7","author":"Rodgers","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"7","key":"10.1016\/j.neo.2022.100866_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149895","article-title":"Adrenergicmediated increases in INHBA drive CAF phenotype and collagens","volume":"6","author":"Nagaraja","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.neo.2022.100866_bib0021","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/nprot.2006.427","article-title":"A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)","volume":"1","author":"Ong","year":"2006","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.neo.2022.100866_bib0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1535-7163.MCT-19-0205","article-title":"Verticillin A causes apoptosis and reduces tumor burden in high-grade serous ovarian cancer by inducing DNA damage","volume":"19","author":"Salvi","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.neo.2022.100866_bib0024","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0027","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12935-019-1022-8","article-title":"PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin \u03b23","volume":"19","author":"Soriano","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"17","key":"10.1016\/j.neo.2022.100866_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-017-0040-z","article-title":"PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma","volume":"37","author":"Ghannam-Shahbari","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2022.100866_bib0029","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-14-292","article-title":"A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells","volume":"14","author":"Di Palma","year":"2014","journal-title":"BMC Cancer"},{"issue":"27","key":"10.1016\/j.neo.2022.100866_bib0030","first-page":"41929","article-title":"Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma","volume":"7","author":"de","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0031","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41467-021-22708-w","article-title":"Bachmann Salvy M, et\u00a0al. PAX8 and MECOM are interaction partners driving ovarian cancer","volume":"12","author":"Bleu","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.neo.2022.100866_bib0032","article-title":"In Vitro tumor models: advantages, disadvantages, variables, and selecting the right platform","volume":"4","author":"Katt","year":"2016","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"13","key":"10.1016\/j.neo.2022.100866_bib0033","doi-asserted-by":"crossref","first-page":"e87988","DOI":"10.1172\/jci.insight.87988","article-title":"Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors","volume":"1","author":"Elias","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.neo.2022.100866_bib0034","doi-asserted-by":"crossref","first-page":"108316","DOI":"10.18632\/oncotarget.22718","article-title":"The PAX8 cistrome in epithelial ovarian cancer","volume":"8","author":"Adler","year":"2017","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.neo.2022.100866_bib0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1089\/thy.2012.0357","article-title":"Functional analysis of the murine Pax8 promoter reveals autoregulation and the presence of a novel thyroid-specific DNA-binding activity","volume":"23","author":"di Gennaro","year":"2013","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.neo.2022.100866_bib0036","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.neo.2022.100866_bib0037","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan Inhibits Collagen I Synthesis and Improves the Distribution and Efficacy of Nanotherapeutics in Tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0038","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00004872-199507001-00002","article-title":"Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension","volume":"13","author":"Siegl","year":"1995","journal-title":"J. Hypertens. Suppl."},{"issue":"3","key":"10.1016\/j.neo.2022.100866_bib0039","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI118838","article-title":"Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats","volume":"98","author":"Volpert","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"Suppl 8","key":"10.1016\/j.neo.2022.100866_bib0040","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.21037\/atm.2019.10.100","article-title":"Proteomic analysis of PAX8 alterations provides new insights into its role as a master regulator of migration in high-grade serous ovarian cancer","volume":"7","author":"Gamberi","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.neo.2022.100866_bib0041","doi-asserted-by":"crossref","first-page":"e44306","DOI":"10.7554\/eLife.44306","article-title":"PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors","volume":"8","author":"Shi","year":"2019","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.neo.2022.100866_bib0042","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","article-title":"Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers","volume":"8","author":"Pearce","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2022.100866_bib0043","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/bjc.2016.426","article-title":"Enrichment of Putative PAX8 Target Genes at Serous Epithelial Ovarian Cancer Susceptibility Loci","volume":"116","author":"Kar","year":"2017","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/j.neo.2022.100866_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108978","article-title":"Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube","volume":"35","author":"Dinh","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.neo.2022.100866_bib0045","doi-asserted-by":"crossref","first-page":"19950","DOI":"10.1038\/s41598-019-56276-3","article-title":"Up-regulated fibronectin in 3D culture facilitates spreading of triple negative breast cancer cells on 2D through integrin \u03b2-5 and Src","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neo.2022.100866_bib0046","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/03602538409041080","article-title":"Captopril: pharmacology, metabolism, and disposition","volume":"15","author":"Migdalof","year":"1984","journal-title":"Drug Metab. Rev."},{"issue":"10","key":"10.1016\/j.neo.2022.100866_bib0047","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2022.100866_bib0048","doi-asserted-by":"crossref","unstructured":"Chaves-Moreira D, Mitchell MA, Arruza C, Rawat P, Sidoli S, Nameki R, et\u00a0al. PAX8 orchestrates an angiogenic program through interaction with SOX17 [Internet]. bioRxiv; 2020 [cited 2022 Jan 21]. p. 2020.09.09.290387. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2020.09.09.290387v1.","DOI":"10.1101\/2020.09.09.290387"},{"issue":"12","key":"10.1016\/j.neo.2022.100866_bib0049","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/s41388-022-02210-3","article-title":"SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:13:39Z","timestamp":1761484419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":47,"alternative-id":["S1476558622000914"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100866","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100866"}}